Lamotrigina Azevedos

Lamotrigine, the active ingredient in Lamotrigina Azevedos, is an anticonvulsant presented as an oral tablet for oral use. It is prescribed to manage seizures in epilepsy and to stabilize mood in bipolar disorder across adult and pediatric populations as directed by a healthcare professional.

GNH USA supplies Lamotrigina Azevedos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from consistent batch release and regulatory compliance.

Lamotrigine is used in the management of seizure disorders and mood stabilization, targeting specific neurological pathways.

- Epilepsy: Reduces the frequency, severity, and duration of both partial‑onset and generalized tonic‑clonic seizures, improving overall seizure control. - Bipolar disorder: Contributes to mood stabilization by decreasing the occurrence of depressive and manic episodes, supporting long‑term maintenance therapy. - Adjunctive therapy: Used alongside other antiepileptic drugs when seizure control is insufficient, enhancing overall efficacy. - Maintenance treatment: Provides long‑term prophylaxis to prevent seizure recurrence after initial stabilization, reducing relapse risk.

Lamotrigine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: mild vertigo or light‑headedness. - Headache: transient cranial discomfort. - Nausea: occasional stomach upset. - Rash: mild skin irritation or erythema. - Blurred vision: temporary visual disturbance.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe, potentially life‑threatening skin reaction. - Aplastic anemia: rare blood disorder with low cell counts. - Hepatic failure: serious liver injury requiring immediate medical attention.

When prescribing lamotrigine, clinicians should observe several precautionary measures to ensure patient safety.

- Monitor blood counts: regular CBC testing to detect hematologic abnormalities. - Avoid abrupt discontinuation: taper dose gradually to reduce seizure risk. - Use caution in hepatic impairment: adjust dose if liver function is compromised. - Assess for skin reactions: discontinue immediately if rash develops. - Pregnancy: evaluate risk‑benefit and consider alternative therapy if possible. - Store at ambient temperature: keep tablets in original container, protect from moisture and light.

Lamotrigine interacts with several medicines that can alter its plasma concentration or increase toxicity.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels, raising risk of severe rash. - Carbamazepine: reduces lamotrigine concentrations, potentially decreasing efficacy. - Phenytoin: lowers lamotrigine levels, may require dose adjustment. - Oral contraceptives: elevate lamotrigine levels, necessitating monitoring. - Enzyme inducers (e.g., rifampicin): significantly decrease lamotrigine exposure.

Moderate Interactions (Monitor Closely): - Serotonergic agents: possible additive risk of serotonin syndrome. - Other antiepileptics (e.g., phenobarbital): may require dose modifications.